321 related articles for article (PubMed ID: 26222264)
1. Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.
Saniee P; Shahreza S; Siavoshi F
Helicobacter; 2016 Apr; 21(2):143-52. PubMed ID: 26222264
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
Nakao M; Malfertheiner P
Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
[TBL] [Abstract][Full Text] [Related]
3. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitor-Treated H. pylori Adjust Cell Envelope Fatty Acid and Cholesterol Content to Survive.
Kadkhodaei S; Siavoshi F; Foroumadi A; Sarrafnejad A; Kolahdoozan S
Arch Iran Med; 2020 Jan; 23(1):7-14. PubMed ID: 31910629
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
[TBL] [Abstract][Full Text] [Related]
6. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
Midolo PD; Turnidge JD; Lambert JR; Bell JM
Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
Dattilo M; Figura N
J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
Tsuchiya M; Imamura L; Park JB; Kobashi K
Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a locally produced rapid urease test for the diagnosis of Helicobacter pylori infection.
Levin DA; Watermeyer G; Mohamed N; Epstein DP; Hlatshwayo SJ; Metz DC
S Afr Med J; 2007 Dec; 97(12):1281-4. PubMed ID: 18264610
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M; Tada M; Tsuchimori K; Uekata M
Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination.
Siavoshi F; Saniee P; Khalili-Samani S; Hosseini F; Malakutikhah F; Mamivand M; Shahreza S; Sharifi AH
Ann Transl Med; 2015 Jan; 3(1):11. PubMed ID: 25705643
[TBL] [Abstract][Full Text] [Related]
12. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors.
Graham DY; Opekun AR; Hammoud F; Yamaoka Y; Reddy R; Osato MS; El-Zimaity HM
Am J Gastroenterol; 2003 May; 98(5):1005-9. PubMed ID: 12809820
[TBL] [Abstract][Full Text] [Related]
13. Effect of omeprazole on Helicobacter pylori urease activity in vivo.
Stoschus B; Domínguez-Muñoz JE; Kalhori N; Sauerbruch T; Malfertheiner P
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):811-3. PubMed ID: 8864680
[TBL] [Abstract][Full Text] [Related]
14. The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection.
Logan RP
Pharmacol Ther; 1996; 69(1):79-83. PubMed ID: 8857304
[TBL] [Abstract][Full Text] [Related]
15. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
Marusic M; Babic Z; Nesanovic M; Lucijanic-Mlinac M; Stajcar V
World J Gastroenterol; 2005 Apr; 11(15):2334-6. PubMed ID: 15818748
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic diagnosis of Helicobacter pylori infection by rapid urease test in bleeding peptic ulcers: a prospective case-control study.
Tang JH; Liu NJ; Cheng HT; Lee CS; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Cheng CL
J Clin Gastroenterol; 2009 Feb; 43(2):133-9. PubMed ID: 19230239
[TBL] [Abstract][Full Text] [Related]
17. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
[TBL] [Abstract][Full Text] [Related]
18. Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding.
Peitz U; Leodolter A; Wex T; Schütze D; Wolle K; Welte T; Günther T; Schmidt U; Malfertheiner P
Z Gastroenterol; 2004 Feb; 42(2):141-6. PubMed ID: 14963786
[TBL] [Abstract][Full Text] [Related]
19. Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test.
Shirin H; Frenkel D; Shevah O; Levine A; Bruck R; Moss SF; Niv Y; Avni Y
Am J Gastroenterol; 2003 Jan; 98(1):46-50. PubMed ID: 12526935
[TBL] [Abstract][Full Text] [Related]
20. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Asaoka D; Nagahara A; Matsuhisa T; Takahashi S; Tokunaga K; Kawai T; Kawakami K; Suzuki H; Suzuki M; Nishizawa T; Kurihara N; Ito M; Sasaki H; Omata F; Mizuno S; Torii A; Ohkusa T; Mine T; Sakaki N
Helicobacter; 2013 Dec; 18(6):468-72. PubMed ID: 23773231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
